To enhance the ability of RMPs to polarize M2Ф and kill tumor cells, we also loaded RMPs with the USP7 inhibitor P5091; the acquisition strategy for P5091@RMPs‐R4F is shown in Figure 2F. The gene discussed is USP7; the disease is neoplasm.